Four Seattle Biotech Firms Looking to Hire Hundreds of New Employees
Ex-Pfizer (PFE) Exec to Head Synthetic Biology Company Synlogic
Pfizer (PFE) Board Member Jumps Ship to $217 Million Startup Denali
Pfizer (PFE) Will Make $120 Billion Bid for GlaxoSmithKline (GSK) in Second Quarter, Says Poll
Regeneron (REGN) and Sanofi (SAN.PA) Partnership Records Another Hit In Latest String of Successes
Stock Soars as bluebird bio (BLUE) Gives Sneak Peek at Promising Sickle Cell Data
Introducing PfizerKline: Analyst Makes New Case for Merger of GlaxoSmithKline (GSK) and Pfizer (PFE)
Indiana Biosciences CEO Has Aggressive Growth Plan, Looks to Hire Hundreds
Johnson & Johnson (JNJ) Announced 10 New Approval Applications with $1 Billion Revenue Potential Each
New FDA Warning Impacts Diabetes Drugs Made by AstraZeneca PLC (AZN), Johnson & Johnson (JNJ) and Eli Lilly (LLY)
Lpath (LPTN) Shares Fall 80%, Will Cut Jobs After Second Drug Flunks Phase II Trial
Judge Berates Bayer (BAY) for Offering to Reinstate Whistleblowing Sales Rep With a Job 500 Miles Away
World's Most Expensive Medicine: Is it Worth It?
REGENXBIO Banks $70.5 Million As Gene Therapy Enjoys Revival
Amgen (AMGN), Sanofi (SAN.PA) in Race to Get European Green light for Anti-Cholesterol Drugs
ASCO’s Most Important Abstracts: BioSpace (DHX)’s Cheat Sheet for You
Why Denali Raised A $217 Million Financing Round: Not Just "Because It Could"
Achillion (ACHN), Johnson & Johnson (JNJ) Hammer Out $1 Billion+ Hep C R&D Pact to Compete With Gilead (GILD) and AbbVie (ABBV)
See All News >
//-->